Parabilis Medicines Inc
PBLSHealthcare·Biotechnology·USA·Mid·NASD·Nov 13 • 7:04 AM ET
26.90-0.79 (-2.85%)
2026-11-13 13:52 CET
Market cap
$3.32B
Revenue, TTM
2.11 USD m
Net income, TTM
-44.49 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-0.36
Price
PBLS against its 20 and 50-day averagesPatternshover a marker to name it
36.7% under the 52-week high of 42.49 on 18 Sep 2026. 52-week low 22.66 on 16 Oct 2026. Last 15 sessions, 36.6% high to low
Volume 0.01× normal · the line is the 50-bar volume average
Setup. RS line 7
CANSLIM 2 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High — not on the tape: EPS Growth This Year: High (>25%); Performance: Year +50%
VCP 2 of 6 — fails: 52-Week High/Low: 0-10% below High; Average True Range: Under 2 — not on the tape: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200
Minervini 0 of 4 — fails: 52-Week High/Low: 0-10% below High — not on the tape: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5 — not on the tape: 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 52-Week High/Low: 0-10% below High — not on the tape: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50 — not on the tape: 200-Day Simple Moving Average: Price above SMA200
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%) — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — not on the tape: Return on Equity: Over +15%; Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2 — not on the tape: P/E: Under 15; Return on Equity: Over +15%
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — not on the tape: 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 2 of 4 — not on the tape: 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — not on the tape: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
PBLS52-week range, 21% of the way up
22.6642.49
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
| Index | RUT |
|---|---|
| IPO | Jun 10, 2026 |
| ATR, 14d | 2.24 |
| Rel volume | 0.01 |
| Short float | 14.26% |
| Insider own | 37.28% |
| Inst own | 52.58% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $3.32B |
| Enterprise Value | 2.49B |
| Income | - |
| Sales | - |
| Book / share | 8.48 |
| Cash / share | 7.06 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | - |
| IPO | Jun 10, 2026 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | - |
| Price / book | 3.17 |
| Price / cash | 3.81 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | - |
| Quick Ratio | 17.91 |
| Current Ratio | 12.88 |
| Debt / equity | 0.04 |
| Long-term debt / equity | 0.03 |
| Options and short | Yes / Yes |
Earnings
Ownership
| Insiders own | 37.28% |
|---|---|
| Insider trades | 91.17% |
| Institutions own | 52.58% |
| Institution trades | 113.62% |
| Return on assets | - |
| Return on equity | - |
| Return on capital | - |
| Gross Margin | - |
| Operating margin | - |
| Profit Margin | - |
| 20-day average | -3.28% |
| 50-day average | -12.76% |
| 200-day average | -15.69% |
Technical
| Shares out | 123.53M |
|---|---|
| Shares floating | 77.48M |
| Short / float | 14.26% |
| Short ratio | 11.82 |
| Short interest | 11.05M |
| 52-week high | 42.49 -36.7% |
| 52-week low | 22.66 +18.7% |
| Volatility | 7.32% 8.84% |
| Average range | 2.24 |
| Strength index | 44.11 |
| Market sensitivity | - |
| Relative volume | 0.01 |
| Avg Volume | 934.94K |
| Volume | 321 |
Performance
| Perf Week | -5.71% |
|---|---|
| Perf Month | 6.83% |
| Perf Quarter | -27.73% |
| Perf Half Y | - |
| Perf YTD | -19.34% |
| Perf Year | - |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 41.00 |
| Prev Close | 27.69 |
| Price | 26.90 |
| Change % | -2.85% |
Analyst ratings
latest 6 of 6| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Nov 09, 2026 | Initiated | Canaccord Genuity | Buy | $39 | +45.0% |
| Oct 22, 2026 | Initiated | H.C. Wainwright | Buy | $40 | +48.7% |
| Jul 06, 2026 | Initiated | Leerink Partners | Outperform | $40 | +48.7% |
| Jul 06, 2026 | Initiated | Guggenheim | Buy | $40 | +48.7% |
| Jul 06, 2026 | Initiated | Evercore ISI | Outperform | ||
| Jul 06, 2026 | Initiated | BofA Securities | Buy | $45 | +67.3% |
Peers
Mkt capInsider trading
8 filings| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 20 '26 | Buy | 27.28 | 131,420 | 3,584,887 | 26,416,513 | Jul 22 04:55 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 21 '26 | Buy | 29.25 | 65,923 | 1,928,032 | 26,482,436 | Jul 22 04:55 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 22 '26 | Buy | 29.77 | 47,250 | 1,406,632 | 26,529,686 | Jul 22 04:55 PM |
| Levy Guy | 10% Owner | Jun 11 '26 | Buy | 20.00 | 500,000 | 10,000,000 | 1,027,000 | Jun 29 10:41 AM |
| SEBULSKY ALAN | Director | Jun 15 '26 | Buy | 26.49 | 9,065 | 240,135 | 30,000 | Jun 16 06:19 PM |
| SEBULSKY ALAN | Director | Jun 12 '26 | Buy | 27.67 | 8,435 | 233,393 | 20,935 | Jun 16 06:19 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jun 11 '26 | Buy | 20.00 | 21,188,750 | 423,775,000 | 26,285,093 | Jun 15 06:57 PM |
| SEBULSKY ALAN | Director | Jun 11 '26 | Buy | 20.00 | 12,500 | 250,000 | 12,500 | Jun 15 05:27 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| VBR | Vanguard Morningstar Small-Cap Value ETF | AUM: 37.88B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| IWN | iShares Russell 2000 Value ETF | AUM: 14.17B |
| FESM | Fidelity Enhanced Small Cap Core ETF | AUM: 6.90B |
Quarterly earnings
2026Q3 EPS -0.360 matched -0.360. Sales 2.11 beat 0.38
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-12 08:30 | -0.360 | -0.360 | -0.360 | 2.11 | 0.38 | EPS 0.0% · sales +463.7% | - | 5 EPS · 4 sales | Open -0.37% vs SPY -0.77%. Close -6.61% vs SPY -0.35% |
| 2026Q2ended 2026-06-30 | 2026-08-13 08:30 | -2.320 | -0.165 | -0.542 | 0.12 | 16.67 | EPS +1306.1% · sales -99.3% | - | 4 EPS · 3 sales | Open +0.69% vs SPY +0.31%. Close -4.65% vs SPY +0.70% |
| 2026Q1ended 2026-03-31 | 2026-06-03 12:00 | -0.720 | - | -0.600 | 0.00 | - | EPS - · sales - | - | - | - |
| 2026Q4ended 2026-12-31 | - | - | -0.400 | - | - | 0.75 | EPS - · sales - | - | 5 EPS · 4 sales | - |
| 2027Q1ended 2027-03-31 | - | - | -0.380 | - | - | 1.75 | EPS - · sales - | vs 2026Q1, year-ago quarter · EPS - · sales - | 4 EPS · 2 sales | - |
| 2027Q2ended 2027-06-30 | - | - | -0.396 | - | - | 2.20 | EPS - · sales - | vs 2026Q2, year-ago quarter · EPS - · sales - | 4 EPS · 2 sales | - |
| 2027Q3ended 2027-09-30 | - | - | -0.402 | - | - | 2.55 | EPS - · sales - | vs 2026Q3, year-ago quarter · EPS - · sales - | 4 EPS · 2 sales | - |
| 2027Q4ended 2027-12-31 | - | - | -0.407 | - | - | 3.00 | EPS - · sales - | vs 2026Q4, year-ago quarter · EPS - · sales - | 4 EPS · 2 sales | - |
Annual earnings
The earnings feed came back with no years.
Quarterly results
2026Q3 revenue 2.11. Operating margin -2,594%
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026Q4 E -0.40 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026Q4 | E | per share | 2026-11-12 | -0.40 | +6.4% |
| 2026Q4 | R | per share | 2026-11-12 | -0.47 | 0.0% |
| 2026Q4 | S | per share | 2026-11-12 | 0.75 | 0.0% |
| 2026Q3 | E | per share | 2026-11-09 | -0.36 | -8.4% |
| 2026Q3 | R | per share | 2026-10-28 | -0.45 | 0.0% |
| 2026Q3 | S | per share | 2026-10-21 | 0.38 | +12.5% |
| 2026Q2 | E | per share | 2026-07-06 | -0.17 | +98.1% |
| 2026Q2 | R | per share | 2026-07-06 | -0.41 | - |
| 2026Q2 | S | per share | 2026-07-06 | 16.67 | -33.3% |
Estimate history
| Metric | 2024 | 2025 | MRQ |
|---|---|---|---|
| EPS per share | -1.367 | -1.582 | - |
| Sales USD millions | 0 | 0 | - |
| Shares million shares | 118 | 118 | 124 |
| Metric | Q1 '25 | Q2 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|
| EPS per share | -0.407 | -0.364 | -0.6 | -0.542 | -0.36 |
| Sales USD millions | 0 | 0 | 0 | 0 | 2 |
| Shares million shares | 118 | 124 | 118 | 124 | - |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 |
|---|---|---|---|
| Total Revenue | 2.11 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.00 | 2.50+18.5% | 2.11 |
| Gross Profit | 2.11 | -2.50 | -2.11 |
| Selling, General and Administrative Excl. Other | 56.85 | 149.58+20.6% | 124.02 |
| Research and Development | 45.60 | 125.01+24.1% | 100.74 |
| Other Operating Expense | - | 0.00 | 0.00 |
| Operating Income | -54.74 | -152.08 | -126.12 |
| Interest Expense | 0.12 | 1.52+2.0% | 1.49 |
| Unusual Expense | 0.00 | 0.00-100.0% | 0.97 |
| Net Income Before Taxes | -44.49 | -145.89 | -117.91 |
| Income Taxes | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -44.49 | -145.89 | -117.91 |
| Net Income From Continuing Operations | -44.49 | -145.89 | -117.91 |
| Net Income | -44.49 | -186.93 | -161.48 |
| EPS (Recurring) per share | -0.36 | -1.58 | -1.36 |
| EPS (Basic, Before Extraordinaries) per share | -0.36 | -1.58 | -1.37 |
| EPS (Diluted) per share | -0.36 | -1.58 | -1.37 |
| EBITDA | - | -149.58 | -124.02 |
| Non-Operating Income (Expense) | 10.37 | 7.71-27.7% | 10.67 |
| Other After Tax Adjustments | - | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 3.32-23.0% | 4.31 |
| Shares Outstanding million shares | - | 118.150.0% | 118.15 |
| Market Capitalization | 3,420.63 | 3,420.63 | - |
Income statement, quarterly
The feed stopped at 5 periods.
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q26/30/2025 | 2025Q13/31/2025 |
|---|---|---|---|---|---|
| Total Revenue | 2.11 | 0.15 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold Incl. D&A | 0.00 | 0.59-4.8% | 0.61-6.2% | 0.62 | 0.65 |
| Gross Profit | 2.11 | -0.45 | -0.61 | -0.62 | -0.65 |
| Selling, General and Administrative Excl. Other | 56.85 | 50.44+40.5% | 46.85+18.3% | 35.90 | 39.59 |
| Research and Development | 45.60 | 39.38+30.7% | 37.65+11.4% | 30.13 | 33.80 |
| Other Operating Expense | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -54.74 | -50.89 | -47.45 | -36.52 | -40.24 |
| Interest Expense | 0.12 | 0.21-47.5% | 0.29-27.5% | 0.40 | 0.40 |
| Unusual Expense | 0.00 | 5.56 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -44.49 | -52.46 | -45.32 | -34.81 | -38.33 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -44.49 | -52.46 | -45.32 | -34.81 | -38.33 |
| Net Income From Continuing Operations | -44.49 | -52.46 | -45.32 | -34.81 | -38.33 |
| Net Income | -44.49 | -66.95 | -70.88 | -44.99 | -48.11 |
| EPS (Recurring) per share | -0.36 | -0.51 | -0.60 | -0.36 | -0.41 |
| EPS (Basic, Before Extraordinaries) per share | -0.36 | -0.54 | -0.60 | -0.36 | -0.41 |
| EPS (Diluted) per share | -0.36 | -0.54 | -0.60 | -0.36 | -0.41 |
| EBITDA | - | -50.29 | -46.85 | -35.90 | -39.59 |
| Non-Operating Income (Expense) | 10.37 | 4.19+98.6% | 2.43+5.2% | 2.11 | 2.31 |
| Other After Tax Adjustments | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | - | 3.63+342.7% | 1.30+52.9% | 0.82 | 0.85 |
| Gross Margin % | 100.00 | -300.68 | - | - | - |
| Operating Margin % | -2,589.21 | -34,382.43 | - | - | - |
| Net Margin % | -2,104.59 | -45,239.86 | - | - | - |
| Shares Outstanding million shares | - | 123.520.0% | 118.150.0% | 123.52 | 118.15 |
| Market Capitalization | 3,420.63 | 3,233.66 | 3,448.68 | - | - |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 |
|---|---|---|
| Cash & Short Term Investments | 27.71-68.5% | 87.98 |
| Short Term Receivables | 0.00-100.0% | 0.36 |
| Inventories | 0.00 | 0.00 |
| Other Current Assets | 1.65-57.4% | 3.87 |
| Total Current Assets | 29.36-68.2% | 92.21 |
| Net Property, Plant & Equipment | 46.08-12.9% | 52.93 |
| Total Investments and Advances | 2.850.0% | 2.85 |
| Deferred Tax Assets | 11.11-11.8% | 12.59 |
| Other Assets | 2.53+100.8% | 1.26 |
| Total Assets | 91.93-43.2% | 161.85 |
| Short Term Debt Incl. Current Port. of LT Debt | 20.89+122.7% | 9.38 |
| Accounts Payable | 17.27+81.6% | 9.51 |
| Other Current Liabilities | 18.63+37.8% | 13.52 |
| Total Current Liabilities | 56.79+75.2% | 32.41 |
| Long Term Debt | 37.81-33.5% | 56.82 |
| Provision for Risks Charges | 0.00 | 0.00 |
| Deferred Tax Liabilities | 11.11-11.8% | 12.59 |
| Other Liabilities | 2.74-23.5% | 3.58 |
| Total Liabilities | 108.45+2.9% | 105.41 |
| Non-Equity Reserves | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 509.97+15.8% | 440.38 |
| Common Equity | -526.50 | -383.94 |
| Total Shareholders Equity | -16.52-129.3% | 56.44 |
| Accumulated Minority Interest | 0.00 | 0.00 |
| Total Equity | -16.52-129.3% | 56.44 |
| Total Liabilities & Stockholders Equity | 91.93-43.2% | 161.85 |
| Book Value Per Share per share | -4.46 | -3.25 |
| Tangible Book Value Per Share per share | -4.46 | -3.25 |
| Price to Book Ratio ratio | 3.26 | - |
| Return on Assets % | -114.98 | - |
| Return on Equity % | -731.00 | - |
| Return on Invested Capital % | -685.34 | -104.11 |
| Quick Ratio ratio | 0.52 | 2.84 |
| Current Ratio ratio | 0.52 | 2.84 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 |
|---|---|---|---|
| Net Income | - | -145.89 | -117.91 |
| Depreciation | - | 2.50+18.5% | 2.11 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 |
| Other Funds (Non Cash) | - | 10.56-6.3% | 11.27 |
| Funds from Operations | - | -132.83 | -104.54 |
| Extraordinary Item | - | 0.00 | 0.00 |
| Changes in Working Capital | - | 9.12+902.2% | 0.91 |
| Cash from Operating Activities | - | -123.71 | -103.63 |
| Capital Expenditures | - | -0.31 | -0.88 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00 |
| Purchase or Sale of Investments | - | 40.06+28.7% | 31.12 |
| Purchase of Investments | - | -16.66 | -90.86 |
| Sale Or Maturity of Investments | - | 56.73-53.5% | 121.98 |
| Other Uses | - | 0.00 | 0.00 |
| Other Sources | - | 0.00 | 0.00 |
| Cash from Investing Activities | - | 39.76+31.5% | 30.24 |
| Cash Dividends Paid | - | 0.00 | 0.00 |
| Change in Capital Stock | - | 67.46-13.6% | 78.08 |
| Repurchase of Common Pref Stock | - | 0.00 | 0.00 |
| Sale of Common Pref Stock | - | 67.46-13.6% | 78.08 |
| Proceedsfrom Stock Options | - | 67.43-12.4% | 77.01 |
| Issuance or Reduction of Debt, Net | - | -3.08 | 0.00 |
| Change in Long Term Debt | - | -3.08 | 0.00 |
| Issuance of Long Term Debt | - | 0.00 | 0.00 |
| Reduction of Long Term Debt | - | -3.08 | 0.00 |
| Net Financing Active Other Cash Flow | - | 0.00 | 0.00 |
| Other Financing Activities Uses | - | 0.00 | 0.00 |
| Cash from Financing Activities | - | 64.38-17.5% | 78.08 |
| Net Change in Cash | - | -19.57-516.4% | 4.70 |
| Free Cash Flow | - | -124.02 | -104.51 |
Balance sheet, quarterly
The feed stopped at 5 periods.
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q2 | 2025Q1 |
|---|---|---|---|---|---|
| Cash & Short Term Investments | 871.62 | 1,120.70 | 329.04 | - | - |
| Short Term Receivables | 0.44 | 0.00 | 0.00 | - | - |
| Inventories | - | 0.00 | 0.00 | - | - |
| Other Current Assets | 6.95 | 4.70 | 3.03 | - | - |
| Total Current Assets | 879.02 | 1,125.40 | 332.07 | - | - |
| Net Property, Plant & Equipment | 43.80 | 42.73 | 44.35 | - | - |
| Total Investments and Advances | 204.16 | 2.85 | 2.85 | - | - |
| Other Assets | 4.26 | 4.29 | 4.89 | - | - |
| Total Assets | 1,131.24 | 1,175.26 | 384.17 | - | - |
| Short Term Debt Incl. Current Port. of LT Debt | 10.49 | 13.97 | 17.43 | - | - |
| Accounts Payable | 20.21 | 18.52 | 15.04 | - | - |
| Other Current Liabilities | 37.56 | 30.34 | 21.77 | - | - |
| Total Current Liabilities | 68.26 | 62.84 | 54.24 | - | - |
| Long Term Debt | 31.33 | 33.54 | 35.71 | - | - |
| Provision for Risks Charges | - | 0.00 | 0.00 | - | - |
| Other Liabilities | 27.30 | 31.15 | 50.00 | - | - |
| Total Liabilities | 126.89 | 127.53 | 139.95 | - | - |
| Non-Equity Reserves | - | 0.00 | 0.00 | - | - |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 814.54 | - | - |
| Common Equity | 1,004.35 | 1,047.73 | -570.32 | - | - |
| Total Shareholders Equity | 1,004.35 | 1,047.73 | 244.22 | - | - |
| Accumulated Minority Interest | - | 0.00 | 0.00 | - | - |
| Total Equity | 1,004.35 | 1,047.73 | 244.22 | - | - |
| Total Liabilities & Stockholders Equity | 1,131.24 | 1,175.26 | 384.17 | - | - |
| Book Value Per Share per share | - | 8.48 | -4.83 | - | - |
| Tangible Book Value Per Share per share | - | 8.48 | -4.83 | - | - |
| Full-Time Employees people | - | - | 176 | - | - |
| Price to Book Ratio ratio | 3.26 | -5.67 | -6.05 | - | - |
| Return on Invested Capital % | -4.30 | -4.85 | -16.19 | - | - |
| Quick Ratio ratio | - | 17.91 | 6.12 | - | - |
| Current Ratio ratio | 12.88 | 17.91 | 6.12 | - | - |
Cash flow, quarterly
The feed stopped at 5 periods.
| Metric | 2026Q3 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q26/30/2025 | 2025Q13/31/2025 |
|---|---|---|---|---|---|
| Net Income | - | -52.46 | -45.32 | -34.81 | -38.33 |
| Depreciation | - | 0.59-4.8% | 0.61-6.2% | 0.62 | 0.65 |
| Other Funds (Non Cash) | - | 10.73+293.0% | 3.04+14.7% | 2.73 | 2.65 |
| Funds from Operations | - | -41.14 | -41.67 | -31.46 | -35.02 |
| Extraordinary Item | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | - | 37.52+10040.5% | -7.53-965.5% | 0.37 | 0.87 |
| Cash from Operating Activities | - | -3.62 | -49.20 | -31.09 | -34.15 |
| Capital Expenditures | - | -0.62 | -0.37 | -0.02 | -0.07 |
| Net Assets From Acquisitions | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | - | -33.45-236.4% | 0.00-100.0% | 24.53 | 6.76 |
| Purchase of Investments | - | -33.45 | 0.00 | 0.00 | -16.66 |
| Sale Or Maturity of Investments | - | 0.00-100.0% | 0.00-100.0% | 24.53 | 23.43 |
| Other Uses | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | - | -34.06-239.0% | -0.37-105.5% | 24.51 | 6.69 |
| Cash Dividends Paid | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | - | 849.61+8496000.0% | 304.80+352.0% | 0.01 | 67.43 |
| Repurchase of Common Pref Stock | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | - | 849.61+8496000.0% | 304.80+352.0% | 0.01 | 67.43 |
| Proceedsfrom Stock Options | - | 849.03 | 304.61+351.7% | 0.00 | 67.43 |
| Issuance or Reduction of Debt, Net | - | -3.91 | -3.90 | -0.14 | -0.14 |
| Change in Long Term Debt | - | -3.91 | -3.90 | -0.14 | -0.14 |
| Issuance of Long Term Debt | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | - | -3.91 | -3.90 | -0.14 | -0.14 |
| Net Financing Active Other Cash Flow | - | -50.00 | 50.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | - | 795.71 | 350.90+421.5% | -0.14 | 67.29 |
| Net Change in Cash | - | 758.02 | 301.33+656.7% | -6.71 | 39.82 |
| Free Cash Flow | - | -4.24 | -49.57 | -31.11 | -34.23 |
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 14.26% | 11.1M | 77.5M | 884.95K |
| 2026-10-15 | 11.94% | 9.3M | 77.5M | 724.25K |
| 2026-09-30 | 10.66% | 8.3M | 77.5M | 640.59K |
| 2026-09-15 | 7.86% | 6.1M | 77.5M | 521.99K |
| 2026-08-31 | 7.32% | 5.5M | 75.4M | 659.79K |
| 2026-08-14 | 6.97% | 5.3M | 75.4M | 723.31K |
| 2026-07-31 | 5.75% | 5.1M | 89.1M | 830.44K |
| 2026-07-15 | 4.44% | 4.0M | 89.1M | 1.04M |
| 2026-06-30 | 3.11% | 2.8M | 89.1M | 1.45M |
| 2026-06-15 | 1.22% | 1.1M | 91.3M | 2.35M |
Option chain
Expiry 2026-11-20 · underlying 26.90, quoted 13 Nov 07:04 ET · ATM 25.00
Option quotes 11 Nov 15:33 ET. A date on a row is older than the last session (12 Nov). 24 rows.
Implied move 21.38% into expiry (call 3.300 + put 2.450 = 5.750 on 26.90)
Put/call open interest 1.68 (191 puts / 114 calls) · Put/call volume — no calls
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 1 Jan | 15.00 | ITM | 10.60 | 15.50 | 0.00 | 0.00 | 643.0% +94.4 | 0 | 0 | 0 | 0.878 | -0.288 | 0.008 |
| put 23 Oct | OTM | 0.00 | 2.45 | 0.30 | 0.00 | 545.4% 0.0 | 3 | 0 | 0 | -0.120 | -0.281 | 0.008 | |
| call 1 Jan | 17.50 | ITM | 8.30 | 13.00 | 0.00 | 0.00 | 529.1% +81.1 | 0 | 0 | 0 | 0.848 | -0.274 | 0.010 |
| put 1 Jan | OTM | 0.00 | 4.90 | 0.00 | 0.00 | 452.6% 0.0 | 0 | 0 | 0 | -0.146 | -0.271 | 0.010 | |
| call 9 Nov | 20.00 | ITM | 5.70 | 10.50 | 10.50 | 0.00 | 431.2% +70.5 | 6 | 0 | 0 | 0.811 | -0.254 | 0.011 |
| put 26 Oct | OTM | 0.00 | 2.00 | 0.60 | 0.00 | 359.3% 0.0 | 12 | 0 | 0 | -0.189 | -0.250 | 0.011 | |
| call 1 Jan | 22.50 | ITM | 3.50 | 8.00 | 0.00 | 0.00 | 304.7% -55.0 | 0 | 0 | 0 | 0.745 | -0.300 | 0.013 |
| put 19 Oct | OTM | 0.00 | 3.00 | 1.69 | 0.00 | 359.6% 0.0 | 1 | 0 | 0 | -0.255 | -0.298 | 0.013 | |
| call 1 Jan | 25.00 | ATM | 1.10 | 5.50 | 0.00 | 0.00 | 261.6% -143.5 | 1 | 0 | 0 | 0.681 | -0.376 | 0.014 |
| put 6 Nov | ATM | 0.00 | 4.90 | 0.70 | 0.00 | 421.7% 0.0 | 150 | 0 | 0 | -0.305 | -0.385 | 0.015 | |
| call 11 Nov | 30.00 | OTM | 0.00 | 4.90 | 2.50 | 0.00 | 342.3% +20.3 | 45 | 0 | 0 | 0.546 | -0.335 | 0.017 |
| put 6 Nov | ITM | 0.50 | 4.90 | 3.00 | 0.00 | 217.3% -129.0 | 10 | 0 | 0 | -0.461 | -0.354 | 0.016 | |
| call 5 Nov | 35.00 | OTM | 0.00 | 4.90 | 0.35 | 0.00 | 432.7% 0.0 | 3 | 0 | 0 | 0.495 | -0.453 | 0.017 |
| put 4 Nov | ITM | 5.00 | 9.70 | 5.30 | 0.00 | 292.0% -155.9 | 15 | 0 | 0 | -0.511 | -0.460 | 0.016 | |
| call 30 Oct | 40.00 | OTM | 0.00 | 4.90 | 0.35 | 0.00 | 500.7% 0.0 | 38 | 0 | 0 | 0.461 | -0.521 | 0.017 |
| put 18 Sep | ITM | 10.00 | 14.70 | 4.50 | 0.00 | 356.5% -158.9 | 0 | 0 | 0 | -0.543 | -0.526 | 0.016 | |
| call 23 Sep | 45.00 | OTM | 0.00 | 4.90 | 2.30 | 0.00 | 555.5% 0.0 | 7 | 0 | 0 | 0.439 | -0.574 | 0.016 |
| put 1 Jan | ITM | 15.00 | 19.50 | 0.00 | 0.00 | 394.3% -175.8 | 0 | 0 | 0 | -0.565 | -0.577 | 0.016 | |
| call 9 Sep | 50.00 | OTM | 0.00 | 4.90 | 1.50 | 0.00 | 601.5% 0.0 | 12 | 0 | 0 | 0.423 | -0.617 | 0.016 |
| put 1 Jan | ITM | 20.00 | 24.50 | 0.00 | 0.00 | 437.6% -178.5 | 0 | 0 | 0 | -0.580 | -0.619 | 0.016 | |
| call 1 Jan | 55.00 | OTM | 0.00 | 4.90 | 0.00 | 0.00 | 641.0% 0.0 | 0 | 0 | 0 | 0.410 | -0.653 | 0.016 |
| put 1 Jan | ITM | 25.00 | 29.70 | 0.00 | 0.00 | 489.8% -165.8 | 0 | 0 | 0 | -0.592 | -0.654 | 0.016 | |
| call 20 Oct | 60.00 | OTM | 0.00 | 4.90 | 0.13 | 0.00 | 675.6% 0.0 | 2 | 0 | 0 | 0.400 | -0.684 | 0.016 |
| put 1 Jan | ITM | 30.00 | 34.50 | 0.00 | 0.00 | 507.6% -182.6 | 0 | 0 | 0 | -0.602 | -0.684 | 0.016 |
Latest SEC filings
30 of 65AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-11-12, period ended 2026-09-30. 10-K was not on the first page of annual reports. PBLS on EDGAR
page 1 of 3Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-12 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001193125-26-458388 index |
| 2026-11-12 | 8-K | All annual, quarterly, and current reports | 2026-11-12 | 0001193125-26-456892 index |
| 2026-11-05 | 8-K | All annual, quarterly, and current reports | 2026-10-30 | 0001193125-26-449869 index |
| 2026-09-15 | 8-K | All annual, quarterly, and current reports | 2026-09-15 | 0001193125-26-391952 index |
| 2026-09-02 | 8-K | All annual, quarterly, and current reports | 2026-08-28 | 0001193125-26-380171 index |
| 2026-08-25 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-22 · transaction | 0001193125-26-365484 index |
| 2026-08-25 | 3 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-22 | 0001193125-26-365459 index |
| 2026-08-25 | 8-K | All annual, quarterly, and current reports | 2026-08-22 | 0001193125-26-365132 index |
| 2026-08-14 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0001193125-26-352189 index |
| 2026-08-13 | 10-Q | All annual, quarterly, and current reports | 2026-06-30 | 0001193125-26-349168 index |
| 2026-08-13 | 8-K | All annual, quarterly, and current reports | 2026-08-13 | 0001193125-26-347869 index |
| 2026-08-06 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0000315066-26-002123 index |
| 2026-07-22 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-07-20 · transaction | 0001231919-26-000779 index |
| 2026-06-29 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-11 · transaction | 0001213900-26-072928 index |
| 2026-06-29 | 3 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 | 0001213900-26-072925 index |
| 2026-06-18 | SCHEDULE 13D | Beneficial ownership reports | no report period | 0001346824-26-000178 index |
| 2026-06-16 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-12 · transaction | 0001193125-26-273013 index |
| 2026-06-15 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-11 · transaction | 0001231919-26-000638 index |
| 2026-06-15 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-271344 index |
| 2026-06-15 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-11 · transaction | 0001193125-26-271324 index |
| 2026-06-15 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-11 · transaction | 0001193125-26-271300 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001231919-26-000623 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-11 · transaction | 0001193805-26-000798 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267806 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267802 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267797 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267769 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267766 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267747 index |
| 2026-06-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-06-09 · transaction | 0001193125-26-267733 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 6.92M | 3 | 0 | 0 |
| 2026-06 | 434.50M | 5 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24.49% |
| FMR LLC | 8.80% |
| ARCH Venture Management, LLC | 5.43% |
| venBio Partners LLC | 4.46% |
| Alphabet Inc. | 3.98% |
| Nextech Invest Ltd. | 3.95% |
| REGENERON PHARMACEUTICALS, INC. | 3.37% |
| Siren, L.L.C. | 2.42% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.00% |
| Jupiter Topco LLC | 1.94% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.95% |
| Fidelity Growth Company Fund | 0.90% |
| VANGUARD SMALL-CAP INDEX FUND | 0.68% |
| Select Health Care Portfolio | 0.46% |
| Fidelity Advisor Biotechnology Fund | 0.45% |
| T. Rowe Price Health Sciences Fund, Inc. | 0.41% |
| JPMorgan Small Cap Growth Fund | 0.41% |
| Select Biotechnology Portfolio | 0.35% |
| AB Small Cap Growth Portfolio | 0.28% |
| Fidelity Small Cap Growth Fund | 0.27% |
OakChart. PBLS. Cached 15 minutes. Terms
Some panels did not load: news.